CONTACT
CONTACT

NEWS

Standard Bariatrics® Named as One to Watch

One to Watch

We are honored to be named as one of the top five private companies for investors to watch by the global financial services firm BTIG in their most recent Medical Technology and Digital Health Industry Report. Their report highlights our primary technology—the Titan SGS® surgical stapler which is designed to help surgeons achieve repeatable and consistent outcomes with sleeve gastrectomy. BTIG noted that after a successful launch attested to by the early completion of our Series B funding, they anticipate a strong performance into FY 2022.

We appreciate being recognized by BTIG as we continue to innovate medical technology to help bariatric surgeons in addressing the obesity epidemic. 

Click Here for the Full. Report https://lnkd.in/gHjeuDfm

Learn more about Standard Bariatrics and request training on Titan SGS at standardbariatrics.com.

#thestandardsleeve #sleevgastrectomy #bariatricsurgery

RECENT NEWS

NEW Study

Titan SGS™ Stapler linked to improved 1 year post-op GERD outcomes in new retrospective study. 

Ying L, Rutledge R, Butensky S, Farinas Lugo D, Morton JM, Ringold F. Does stapling platform influence robotic sleeve gastrectomy postoperative outcomes? Obes Surg. 2025;35(4). doi:10.1007/s11695-025-07855-z

 

Dr. Morton and Dr. Ringold, two of the authors of the study, are paid consultants of Teleflex Incorporated.

View the Study

New propensity matched retrospective study reports perioperative outcomes of the Titan SGSTM Stapler.

View the Study

Thank you for joining the community of bariatric surgeons interested in the Titan SGS®.

We'll connect with you soon.

REQUEST TRAINING*

Please fill out the form below to receive training information.

*Titan SGS® is cleared for use by the U.S. Food and Drug Administration (FDA). It is currently only available for purchase and use in the United States of America (USA).